BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Policy

  CDC Chief Plans “Reset” in Response to COVID-19 Criticism

  CDC director Dr. Rochelle Walensky announced plans to launch a “reset” of the agency amid criticism over its handling of the COVID-19 pandemic and other public health threats.

  August 18, 2022

   · 

  4 min read

   · 

  Mark Terry
• 

  Business

  BioSpace Movers & Shakers: Arvinas, Nuvig, Cambridge Isotope and More

  This week’s Movers & Shakers include Arvinas, Inspire and Cambridge Isotope Laboratories all announcing new VP roles, and several others tap new C-suite executives.

  August 18, 2022

   · 

  4 min read

   · 

  Alex Keown
• 

  Drug Development

  Drug Development for Rare Diseases is Littered with Regulatory Roadblocks

  The regulatory path for companies developing drugs for rare diseases is often fraught with challenges. KemPharm CEO Travis Mickle discussed just some of these with BioSpace.

  August 18, 2022

   · 

  5 min read

   · 

  Hayley Shasteen
• 

  Business

  Genentech, Roche Sink Potential $590M into Advanced Prostate Cancer Asset

  Genentech has partnered with Jemincare to develop and commercialize an asset that may provide new treatment options for people with advanced-stage prostate cancer.

  August 18, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  FDA Partially Clears Curis Leukema Trial in Second August Regulatory Win - Updated

  Curis announced that the FDA has allowed patient enrollment to resume in the monotherapy phase of its TakeAim Leukemia Phase I/II trial studying emavusertib.

  August 18, 2022

   · 

  2 min read

   · 

  Chris Moore
• 

  Drug Development

  Genuv Repurposes Novartis’ Cancer Drug to Treat Alzheimer’s - Updated

  South Korea-based Genuv Inc. announced the publication of a preclinical study showing the potential of Mekinist, approved by the FDA for melanoma, in Alzheimer’s disease.

  August 18, 2022

   · 

  3 min read

   · 

  Tristan Manalac
• 

  Policy

  Ivermectin and Others Flunk Severe COVID-19 Study, Vaccine Development Lawsuits Mount

  A trial evaluating generic drugs against severe COVID-19 provided data showing their overall ineffectiveness, and COVID-19-related lawsuits continue to pile up.

  August 18, 2022

   · 

  5 min read

   · 

  Mark Terry
• 

  Drug Development

  Jazz Takes Groundbreaking Epilepsy Drug into Kids in Phase III Trial

  Jazz Pharma is breaking new ground with its cannabidiol epilepsy treatment Epidiolex, taking the drug into a Phase III study in children and adolescents.

  August 18, 2022

   · 

  3 min read

   · 

  Alex Keown
• 

  Research Roundup: Fat Cell Hormone Slows Liver Tumor Growth and More Research News

  A fat hormone that slows liver tumor growth, a genetic map to track tumorigenesis, study that shows we inherit more than expected epigenetic information from our mothers, Alzheimer linked APOE gene protects against glaucoma.

  August 18, 2022

   · 

  4 min read

   · 

  Mark Terry
• 

  Policy

  Bavarian Nordic Seeks Help as Monkeypox Vaccine Supply Line Crumbles

  Cases of monkeypox are growing at an alarming rate and Bavarian Nordic, the company that owns one of the two approved vaccines, may no longer be able to keep up.

  August 18, 2022

   · 

  2 min read

   · 

  Tristan Manalac